Chairman: Andrew J. Levander
Chief Executive Officer: Henry N. Nassau
Managing Partner Almaty: Victor Mokrousov
Managing Partner Beijing: Jingzhou Tao
Managing Partner Singapore: Dean Collins
Number of partners: 307
Number of lawyers: Approximately 1000
Languages: 40+ including Cantonese, Hindi, Kazakh, Korean, Malay, Mandarin, Russian
Dechert is a leading global law firm with 27 offices around the world. Dechert advises on matters and transactions of the greatest complexity, bringing energy, creativity and efficient management of legal issues to deliver commercial and practical advice for clients.
Main Areas of Practice:
Corporate Investigations & Anti-Corruption:
Dechert’s anti-corruption compliance and investigations lawyers in advise companies across a wide range of industries. Services cover all phases of the compliance and risk mitigation timeline, from pre-investment risk assessment to investigations.
Dechert represents buyers, sellers and advisers in complex corporate, commercial and M&A transactions throughout Asia Pacific. Dechert focuses on structuring successful deals, ensuring speed-to-market execution and protecting clients’ interests in all phases of a transaction.
Litigation & Dispute Resolution:
With a proven track record of success in Asia-related matters, Dechert represents clients in complex domestic and cross-border commercial litigation cases. Dechert advises on dispute resolution clauses, pursue litigation or arbitration, obtain interim measures such as injunctions, and enforce judgments and arbitral awards throughout the world.
Energy & Natural Resources:
Dechert advises Asian and non-Asian clients on the full range of transactional, litigation and regulatory matters in all industry subsectors.
Financial Services & Investment Management:
Dechert is a leading advisor to asset managers, investment funds and other financial services firms. Dechert advises on fund formation across the full range of asset classes, management company issues, regulatory and compliance matters, fund and management company transactional matters, commodities and derivatives law, and financial institutions regulation. Among others, the firm advises on hedge, private equity, venture capital, registered and real estate funds.
Foreign Direct Investment:
Dechert helps form subsidiaries and joint ventures in a variety of industries and advises on structuring and tax aspects.
Dechert advises on all aspects of IP protection, including idea development; patent prosecution and portfolio enhancement; trademark, trade secret and copyright protection; and licensing arrangements. International Arbitration Dechert represents states, state entities, majority and minority shareholders in joint ventures, multinational corporations, and other claimants and respondents, and appears in major arbitration centres in Asia, including Hong Kong, Singapore and Beijing.
Dechert navigates complex issues confronting life sciences companies — from start-ups to multinationals in pharmaceuticals, biotechnology, drug discovery, genomics, diagnostics, medical devices, biosimilars, and digital health — as well as the industry’s most active investment banks, venture/growth capital firms and research institutions. The firm works in leading biotech hotbeds around the world, including East Asia.
Dechert advises Asian and global private equity and venture capital funds on formation and investments, and funds on portfolio investments in Asian companies.
Fund managers, intermediaries and banks come to Dechert for comprehensive, multi-jurisdictional financial services expertise that includes corporate and securities-related regulatory guidance, and advice on compliance and internal controls.
Dechert structures, negotiates and executes taxable and tax-free transactions, implements transfer pricing strategies and resolves tax disputes.
White Collar & Securities:
Dechert advises on securities fraud matters; securities transactions disputes; derivative, mutual fund, private equity and financial institution litigation; broker dealer disputes; shareholder derivative proceedings; and director misfeasance and corporate governance.